Yoshimoto Kogyo Chairman Hayashi dies at 62

Yoshimoto Kogyo Chairman Hayashi dies at 62

OSAKA, Japan - Hiroaki Hayashi (in undated file photo), chairman of major entertainment company Yoshimoto Kogyo Co., died Jan. 3 of lung cancer at an Osaka hospital, his family and the company said on Jan. 4. He was 62.

  • Product Code
  • ILEA001218041
  • Registered date
  • 2005/1/04 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2020 Kyodo News
  • Media size
  • 1864 × 803 pixel
  • Resolution
  • dpi
  • Deployment size
  • 129.07(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Sumitomo Chemical's Tokura to become Keidanren chief

    Sumitomo Chemical's Tokura to become Keidanren chief

    Masakazu Tokura, chairman of Sumitomo Chemical Co., seen in this file photo, will replace Hiroaki Nakanishi as head of the Japan Business Federation known as Keidanren, as Nakanishi is to step down on June 1, 2021, due to an ongoing battle with lymphoma, sources familiar with the matter said on May 10.
      Keidanren chief Nakanishi to step down in June due to illness

      Keidanren chief Nakanishi to step down in June due to illness

      Hiroaki Nakanishi, chairman of the Japan Business Federation, seen in this undated file photo, will step down on June 1, 2021, due to an ongoing battle with lymphoma, sources familiar with the matter said on May 10, 2021. Masakazu Tokura, 70, chairman of Sumitomo Chemical Co., will replace Nakanishi, 75, as the head of Japan's most powerful business lobby, also known as Keidanren.
        Ono Pharmaceutical to dispute suit filed by Nobel laureate

        Ono Pharmaceutical to dispute suit filed by Nobel laureate

        File photo taken June 5, 2020, shows the headquarters of Ono Pharmaceutical Co. in Osaka. The company said in a press release issued July 6 that it will "dispute and cope" with a lawsuit filed by Japanese Nobel laureate in medicine Tasuku Honjo the previous month over patent royalties for the cancer treatment drug Opdivo developed based on the discovery of his research team.
          Kansai Electric President Takashi Morimoto

          Kansai Electric President Takashi Morimoto

          Kansai Electric Power Co. President Takashi Morimoto speaks at a press conference following a shareholder meeting in Osaka on June 25, 2020. The company appointed Sadayuki Sakakibara, a former head of the Japan Business Federation, as its new chairman to regain public trust following a scandal in which a former deputy mayor of a town hosting one of its nuclear plants was found to have bribed company executives. (Kyodo) ==Kyodo
            Kansai Electric President Takashi Morimoto

            Kansai Electric President Takashi Morimoto

            Kansai Electric Power Co. President Takashi Morimoto (C) bows at the end of a press conference held following a shareholder meeting in Osaka on June 25, 2020. The company appointed Sadayuki Sakakibara, a former head of the Japan Business Federation, as its new chairman to regain public trust following a scandal in which a former deputy mayor of a town hosting one of its nuclear plants was found to have bribed company executives. (Kyodo) ==Kyodo
              Kansai Electric President Takashi Morimoto

              Kansai Electric President Takashi Morimoto

              Kansai Electric Power Co. President Takashi Morimoto (C) speaks at a press conference following a shareholder meeting in Osaka on June 25, 2020. The company appointed Sadayuki Sakakibara, a former head of the Japan Business Federation, as its new chairman to regain public trust following a scandal in which a former deputy mayor of a town hosting one of its nuclear plants was found to have bribed company executives. (Kyodo) ==Kyodo
                Kansai Electric President Takashi Morimoto

                Kansai Electric President Takashi Morimoto

                Kansai Electric Power Co. President Takashi Morimoto (R) speaks at a press conference following a shareholder meeting in Osaka on June 25, 2020. The company appointed Sadayuki Sakakibara, a former head of the Japan Business Federation, as its new chairman to regain public trust following a scandal in which a former deputy mayor of a town hosting one of its nuclear plants was found to have bribed company executives. (Kyodo) ==Kyodo
                  Kansai Electric President Takashi Morimoto

                  Kansai Electric President Takashi Morimoto

                  Kansai Electric Power Co. President Takashi Morimoto (2nd from L) speaks at a press conference following a shareholder meeting in Osaka on June 25, 2020. The company appointed Sadayuki Sakakibara, a former head of the Japan Business Federation, as its new chairman to regain public trust following a scandal in which a former deputy mayor of a town hosting one of its nuclear plants was found to have bribed company executives. (Kyodo) ==Kyodo
                    Kansai Electric President Takashi Morimoto

                    Kansai Electric President Takashi Morimoto

                    Kansai Electric Power Co. President Takashi Morimoto speaks at a press conference following a shareholder meeting in Osaka on June 25, 2020. The company appointed Sadayuki Sakakibara, a former head of the Japan Business Federation, as its new chairman to regain public trust following a scandal in which a former deputy mayor of a town hosting one of its nuclear plants was found to have bribed company executives. (Kyodo) ==Kyodo
                      In-train spraying of antiviral materials by JR West

                      In-train spraying of antiviral materials by JR West

                      West Japan Railway Co. (JR West) has begun anti-viral and anti-bacterial treatment of the entire interior of its trains, with plans to implement the treatment on about 3,600 cars running in the Keihanshin area by the end of September and eventually on all 5,200 cars on conventional lines. The plan is to ensure the safety and security of passengers under with corona. The system uses chemicals that have been confirmed by a third-party organization to be effective against influenza and noroviruses. The effect will last for several years, the company said. The chemicals will be sprayed on windows, seats and other places where passengers may touch them. The number of commuters and other passengers in the Kansai region is gradually returning following the lifting of the state of emergency declared for the new coronavirus infection on March 21. Kazuaki Hasegawa, president of the company, said, Photo taken on May 22, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images